AS I SEE IT: Investors may be too hasty in writing off the health tech firm’s prospects, says TERRY MURDEN Just a year ago Omega Diagnostics was deemed a rising star of the Scottish health technology sector, its shares soaring from penny stock to more than 100p. Last week they plummeted back to earth, selling […]
